All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 148 of 206 pages ‹ First < 146 147 148 149 150 > Last ›
HSL1124
Grady D.
U.S. Lowers 'Normal' Levels for Blood Pressure Readings
NY Times 2003 May 15
http://www.nytimes.com/2003/05/14/health/14CND-BLOO.html
HSL1125
Zwillich T.
Lawmakers OK Bill to Stop Rx Coercion in Schools
Reuters Health 2003 May 15
HSL1127
Pallarito K.
New Primary Care Journal Refuses Drug Ads
Reuters Health 2003 May 15
HSL9768
Eriksen SA, Nilsen JS, Spigset O, Slordal L.
Selective COX-2 inhibitors--attitudes and prescription habits among general practitioners
Tidsskr Nor Laegeforen. 2003 May 15;123:(10):1334-7
HSL18154
Moynihan R
Blurring the boundaries: Are sponsored news programmes a new form of paid fronts for the pharmaceutical industry?
BMJ 2003 May 15;326:(7398):1094
http://www.bmj.com/cgi/content/full/326/7398/1094
HSL1122
Pfizer Launches 'Zoloft For Everything' Ad Campaign
The Onion (Parody) 2003 May 14
http://www.theonion.com/articles/pfizer-launches-zoloft-for-everything-ad-campaign,297/
HSL1123
Ryerson-cruz G.
Cost of testing drugs quadrupled, study says
Bloomberg News 2003 May 14
HSL18156
Relman AS; ACCME.
Defending professional independence: ACCME's proposed new guidelines for commercial support of CME.
JAMA 2003 May 14;289:(18):2418-20
http://jama.ama-assn.org/cgi/content/full/289/18/2418
HSL18157
Baird P.
Getting it right: industry sponsorship and medical research.
CMAJ 2003 May 13;168:(10):1267-9
http://www.cmaj.ca/cgi/content/full/168/10/1267
HSL18158
Yeo M.
Marketing Rx&D: one step forward, two steps back.
CMAJ 2003 May 13;168:(10):1273-4
http://www.cmaj.ca/cgi/content/full/168/10/1273
HSL18159
Hanson D
Marketing Rx&D: the CMA president responds
CMAJ 2003 May 13;168:(10):1274
http://www.cmaj.ca/cgi/content/full/168/10/1274
HSL1121
Pfizer Narrows Field on Big Assignments
The New York Times 2003 May 12
http://www.nytimes.com/2003/05/12/business/media/12ADDE.html?pagewanted=all&position=
HSL1118
Brook R.
Drug Safety
2003 May 10
HSL1119
Chaddock G.
Profits, politics, and a drug patent: A controversial draft bill offers glimpse of the close dance between a giant drug company and two key senators.
The Christian Science Monitor 2003 May 10
HSL1120
European Union pharmaceutical legislation review
Health Action International 2003 May 10
HSL7641
Hall WD, Mant A, Mitchell PB, Rendle VA, Hickie IB, McManus P.
Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis.
BMJ 2003 May 10;326:(7397):1008
http://www.bmj.com/cgi/content/full/326/7397/1008
HSL18160
Burton B.
Complementary medicines industry in crisis after recall of 1546 products.
BMJ 2003 May 10;326:(7397):1001
http://www.bmj.com/cgi/content/full/326/7397/1001/a?view=long&pmid=12742903
HSL18161
Dyer O.
Lundbeck broke advertising rules.
BMJ 2003 May 10;326:(7397):1004
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1125924/?tool=pubmed
HSL18162
Dunn N.
10-minute consultation: adverse drug event.
BMJ 2003 May 10;326:(7397):1018
http://www.bmj.com/cgi/content/full/326/7397/1018?view=long&pmid=12742925
HSL18164
Leucht S, Wahlbeck K, Hamann J, Kissling W.
New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis.
Lancet 2003 May 10;361:(9369):1581-9
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(03)13306-5
HSL1116
Wallace M.
Schizophrenia drug claims questioned
BBC News 2003 May 9
HSL1117
Frisch D.
Media May Mislead on Drug Study Stories
Reuters Health 2003 May 9
HSL1114
Graham M.
Democracy by Disclosure: The Rise of Technopopulism
2003 May 8
HSL1110
Some News Anchors Paid by Drug Companies
New York Times 2003 May 7
HSL1111
Petersen M.
A Respected Face, but Is It News or an Ad?
The New York Times 2003 May 7
http://www.nytimes.com/2003/05/07/business/media/07DRUG.html
HSL1113
Aaron Brown Turning Pr Flack For Phoney 'Newscasts'
New York Times 2003 May 7
HSL1097
Woodman R.
Generics spark cholesterol drug war in UK, Germany
Reuters 2003 May 5
HSL1108
Abelson R.
For Glaxo, the Answers Are in the Pipeline
The New York Times 2003 May 4
HSL1098
Boseley S.
Seroxat maker abandons 'no addiction' claim: Firm agrees to alter leaflet to patients after complaints
The Guardian 2003 May 3
http://www.guardian.co.uk/society/2003/may/03/medicineandhealth.lifeandhealth
HSL1102
Sweet M.
GlaxoSmithKline takes legal action to block new controls on its smoking cessation drug
BMJ 2003 May 3
http://www.bmj.com/cgi/content/extract/326/7396/952/a
HSL1104
Hope J.
Doctors' Children Avoid MMR in UK
Daily Mail 2003 May 3
http://www.dailymail.co.uk/health/article-179088/Doctors-children-avoid-MMR.html
HSL1106
Gilles G.
Study: Prescription Drug Ads Promote Patient-Doctor Communication
Yale New Haven Health System 2003 May 3
HSL16747
Wolfe SM
Democracy by Disclosure: The Rise of Technopopulism (Book Review)
NEJM 2003 May 3;348:19
HSL18165
Dorozynski A
French government cuts payments for 'moderately useful' drugs
BMJ 2003 May 3;326:(7396):951
http://www.bmj.com/cgi/content/full/326/7396/951/b
HSL18168
Shulman KI, Rochon P, Sykora K, Anderson G, Mamdani M, Bronskill S, Tran CT.
Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence.
BMJ 2003 May 3;326:(7396):960-1
http://www.bmj.com/cgi/content/full/326/7396/960?view=long&pmid=12727769
HSL18169
Mayor S
Helpline for patients to report adverse reactions is piloted in England
BMJ 2003 May 3;326:(7396):951
http://www.bmj.com/cgi/content/full/326/7396/951
HSL18170
Aronson J
TV: Dying for Drugs
BMJ 2003 May 3;326:(7396):990
http://www.bmj.com/cgi/content/full/326/7396/990
HSL1095
AstraZeneca cancer drug linked to 69 new deaths
Reuters 2003 May 2
HSL1088
A Friend Indeed
Newspapers highlight benefits of new drugs, ignore risks
2003 May 01
HSL1092
Pharmaceutical Sales Force Excellence: Medicaid Market Tactics that Increase Sales
BUSINESS WIRE 2003 May 1
HSL1899
Shani S.
[E-commerce of pharmaceuticals]
Harefuah. 2003 May 01;142:(5):372-6, 397, 396
HSL1191
Ma J, Stafford R, Cockburn I, Finkelstein S.
A statistical analysis of the magnitude and composition of drug promotion in the United States in 1998
Clin Ther 2003 May;25:(5):1503-17
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VRS-491PWHT-F&_coverDate=05%2F31%2F2003&_alid=305698650&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=6242&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=237c0513c114f43d1946b9773feb4e9e
HSL1201
Kocs D, Fendrick AM.
Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experience.
Am J Manag Care 2003 May;9:(5):393-400
http://web.archive.org/web/20070527141019/http://www.cbc.ca/disclosure/archives/040217_adr/resources.html
HSL1229
Cline RJ.
At the intersection of micro and macro: opportunities and challenges for physician-patient communication research.
Patient Educ Couns 2003 May;50:(1):13-6
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6TBC-48CG0WX-9&_coverDate=05%2F31%2F2003&_alid=272783093&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=5139&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=5ebae07eeb92b44d334068747b9d8b54
HSL1236
Burgmer M, Driesch G, Heuft G.
[The "Sisi syndrome": a new form of depression?]
Nervenarzt 2003 May;74:(5):440-4
HSL1418
Jureidini J, Tonkin A.
Paroxetine in major depression.
J Am Acad Child Adolesc Psychiatry 2003 May;42:(5):514
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0890-8567&volume=42&issue=5&spage=514
HSL2343
Brody H.
Pens and other pharmaceutical industry gifts.
Am J Bioeth 2003 Summer;3:(3):58-60
HSL7396
Parry V.
The Art of Branding a Condition
Medical Marketing and Media 2003 May;42-49
http://www.mmm-online.com/content/fileadmin/files/features/2003/CONDITION.pdf
HSL9747
The truth is out there.
Lancet Neurol. 2003 May;2:(5):261
http://linkinghub.elsevier.com/retrieve/pii/S1474442203004010
HSL10378
Schiano TD.
Hepatotoxicity and complementary and alternative medicines.
Clin Liver Dis 2003 May;7:(2):453-73
HSL10464
Williams SA, Ray A.
The impact of clinical technologies on R& D productivity
Current Drug Discovery 2003 May;17-22
HSL10472
Nathwani D.
Impact of methicillin-resistant Staphylococcus aureus infections on key health economic outcomes: does reducing the length of hospital stay matter?
J Antimicrob Chemother 2003 May;51:
http://jac.oxfordjournals.org/cgi/reprint/51/suppl_2/ii37
HSL10488
Watanabe I, Tomita A, Shimizu M, Sugawara M, Yasumo H, Koishi R, Takahashi T, Miyoshi K, Nakamura K, Izumi T, Matsushita Y, Furukawa H, Haruyama H, Koga T.
A study to survey susceptible genetic factors responsible for troglitazone-associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus.
Clin Pharmacol Ther 2003 May;73:(5):435-55
HSL18171
Sorokin M, Mansfield PR.
Revealing all.
Lancet Infect Dis 2003 May;3:(5):270-1
http://linkinghub.elsevier.com/retrieve/pii/S1473309903006029
HSL1087
Boseley S.
Drugs firm broke advertising rules
The Guardian 2003 Apr 30
http://www.guardian.co.uk/media/2003/apr/30/advertising.medicineandhealth
HSL1085
Ackerman T.
Doctors aim to end conflicts of interest: Cancer specialists issue new guidelines
Houston Chronicle 2003 Apr 29
HSL1086
Heil E.
Frist Predicts Passage Of Medicare Reform Legislation ...
2003 Apr 29
HSL1233
Cassels A, Hughes MA, Cole C, Mintzes B, Lexchin J, McCormack JP.
Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs.
CMAJ 2003 Apr 29;168:(9):1133-7
http://www.cmaj.ca/cgi/content/full/168/9/1133
HSL1082
Richwine L.
US warns drug makers about doctor payments, gifts
Reuters 2003 Apr 28
HSL1083
Elliott V.
FDA chief pledges changes to direct-to-consumer advertising guidelines
AMNews 2003 Apr 28
http://www.ama-assn.org/amednews/2003/04/28/hlsd0428.htm
HSL1084
Dr Mercola.
Drug Companies Engage in Illegal Sales Practices: U.S. Issues Warning
Mercola.com 2003 Apr 28
HSL17929
Pear R
U.S. Warns Drug Makers on Illegal Sales Practices
The New York Times 2003 Apr 28
http://www.nytimes.com/2003/04/28/us/us-warns-drug-makers-on-illegal-sales-practices.html?pagewanted=1?pagewanted=1
HSL1081
Pollack A.
Talking Up a Drug for This (and That)
The New York Times 2003 Apr 27
http://www.nytimes.com/2003/04/27/business/talking-up-a-drug-for-this-and-that.html?scp=9&sq=
HSL1079
Kaufman M.
FDA Says It Can Force Change in Drug Sales Status
Washington Post 2003 Apr 26
HSL1080
Confessions of a ten-a-day man
The Guardian 2003 Apr 26
http://www.guardian.co.uk/society/2003/apr/26/health.healthandwellbeing
HSL18180
Dyer O.
Drug companies pay out millions after overcharging Medicaid.
BMJ 2003 Apr 26;326:(7395):900
http://www.ncbi.nlm.nih.gov/pubmed/12714466
HSL10503
Figueras A, Laporte JR.
Failures of the therapeutic chain as a cause of drug ineffectiveness.
BMJ 2003 Apr 26;326:(7395):895-6
http://www.bmj.com/cgi/content/full/326/7395/895
HSL1076
Kramer T.
Practitioners and the Pharmaceutical Industry
2003 Apr 25
HSL1075
Hallam K.
Amgen Becomes No. 2 Grassley Donor as Aranesp Debated
2003 Apr 24
HSL1077
Dr Mercola.
Are Drug Companies Next Target After Tobacco?
Mercola.com 2003 Apr 24
HSL1078
The Drugs Industry: Where The Money Is - Is Big Pharma the next target for attack?
The Economist 2003 Apr 24
HSL1070
Hallam K.
Lilly, Merck, Drug Lobby Fight Price Cuts by States
2003 Apr 23
HSL1071
Petersen M.
Drug Makers Expand Their Medicaid Role
The New York Times 2003 Apr 23
HSL17926
Tanner L
Medical journal blasts early end of drug trial: Stopping study for financial reasons unethical, editors say
The Associated Press 2003 Apr 23
HSL1072
MacPherson K.
Pharmacia denounced for halting drug study : Research questioned its medicine's value
Star-Ledger Staff 2003 Apr 23
HSL1073
Martinez B.
Merck Kills Medco IPO Plan,Will Spin Off Unit to Holders : Drug Firm Says Market
THE WALL STREET JOURNAL 2003 Apr 23
HSL1074
Hallam K.
Sen. Kennedy to Press for $700 Bln Prescription Drug Proposal
2003 Apr 23
HSL18186
Psaty BM, Rennie D.
Stopping medical research to save money: a broken pact with researchers and patients.
JAMA 2003 Apr 23-30;289:(16):2128-31
http://jama.ama-assn.org/cgi/content/full/289/16/2128
HSL1065
McGinley L.
Dispute Over Anemia Drug Is Dragged to Capitol Hill: Amgen, J&J Take 18-Year Fight For Market Control to Legislators
The Wall Street Journal 2003 Apr 22
HSL1066
Kolata G.
Hormone Studies: What Went Wrong?
The New York Times 2003 Apr 22
http://www.nytimes.com/2003/04/22/science/hormone-studies-what-went-wrong.html
HSL1067
Langone J.
Reducing Torment of PMS
The New York Times 2003 Apr 22
http://www.nytimes.com/2003/04/22/health/books-on-health-reducing-torment-of-pms.html
HSL1069
Journal Criticizes Halting Drug Study : Top Medical Journal Condemns Pharmaceutical Industry Over Halted Blood
2003 Apr 22
HSL1064
Pharmaceutical firm cuts drug sales to Canada to fight cross-border buying
Associated Press 2003 Apr 21
HSL1059
Templeton S.
Drugs firms 'cure the rich' claim
Sunday Herald 2003 Apr 20
HSL1060
Elmore C.
What you need to know about pill pitchers
Palm Beach Post 2003 Apr 20
HSL10490
Links.
Moves to eliminate 'anticompetitive' practices in the supply of prescription-only veterinary medicines.
Vet Rec 2003 Apr 19;152:(16):482-4
HSL1058
Peirol P.
Benefits in sick bay
2003 Apr 18
HSL1055
Harris G.
Bitter Pill: 'Branded Generics' Eat Into Drug Makers' Profits: Generic Drug Makers Use Altered Copies To Outmaneuver Patents in Legal Battles
Wall Street Journal 2003 Apr 17
HSL1056
Ripping Off the Rights of Children: Drug Companies are Enlisting the Help of Heavy Hitters to Protect Themselves from Liability
PRNewswire 2003 Apr 17
HSL1057
Petersen M.
Bayer Agrees to Pay U.S. $257 Million in Drug Fraud
The New York Times 2003 Apr 17
http://www.nytimes.com/2003/04/17/business/17DRUG.html
HSL18181
Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, Seger DL, Shu K, Federico F, Leape LL, Bates DW.
Adverse drug events in ambulatory care.
N Engl J Med 2003 Apr 17;348:(16):1556-64
http://content.nejm.org/cgi/content/abstract/348/16/1556
HSL18182
Iglehart JK.
Medicare and drug pricing.
N Engl J Med 2003 Apr 17;348:(16):1590-7
http://content.nejm.org/cgi/content/extract/348/16/1590
HSL1051
Christensen D.
FDA Reorganization Intended to Streamline Review Process for Biologics
Journal of the National Cancer Institute, 2003 Apr 16;95:(8):576-577
http://jnci.oxfordjournals.org/cgi/content/extract/95/8/576
HSL1052
Frost G.
Bayer Agrees to Biggest Medicaid Fraud Settlement
USA Today 2003 Apr 16
http://www.usatoday.com/money/industries/health/drugs/2003-04-16-drug-settlement_x.htm
HSL1053
Glaxo and Bayer Settle U.S. Medicaid Fraud Charges
REUTERS 2003 Apr 16
HSL1054
Dotinga R.
Mental Illness Strikes Babies, Too
HealthScoutNews 2003 Apr 16
HSL1129
Little Pharma is a business: Get Used To The Idea
2003 Apr 16
HSL5175
Berwick DM.
Disseminating innovations in health care.
JAMA 2003 Apr 16;289:(15):1969-75
http://jama.ama-assn.org/cgi/content/full/289/15/1969
HSL18172
West R, Borden EK, Collet JP, Rawson NS, Tonks RS.
A national drug agency.
CMAJ 2003 Apr 15;168:(8):962-3
http://www.cmaj.ca/cgi/content/full/168/8/962-c
HSL1203
Jorgensen J, Djurhuus JC.
[Openness in the cooperation between physicians and private corporations]
Ugeskr Laeger. 2003 Apr 14;165:(16):1642-5
Page 148 of 206 pages ‹ First < 146 147 148 149 150 > Last ›
